A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor

https://doi.org/10.1016/0014-2999(89)90362-2Get rights and content

Abstract

A-69024 HBr, 1-(2-bromo-4,5-dimethoxybenzyl)-7-hydroxy-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline hydrobromide, is a selective antagonist of the dopamine D-1 receptor. A-69024 HBr shows an apparent affinity toward the D-1 receptor (identified using [125I]SCH 23390) of 12.6 (4.15–38.3) nM (mean (90% CL), n = 3); the apparent affinity toward the D-2 receptor (identified using [3H]spiroperidol is 1 290 (1 200–1 380) nM (n = 3); using [125I]lysergic acid diethylamine to identify the 5-HT1C receptor gives apparent affinity of 17 800 (9 700–32 600) nM (n = 3). In assays of adenylate cyclase activity, A-69024 HBr antagonizes the D-1 receptor with a calculated affinity of 43.9 (17.5–110) nM (n = 5), while the molecule antagonizes the D-2 receptor with a calculated affinity greater than 400 nM. Behavioral studies demonstrate that A-69024 HBr (5 mg/kg s.c.) is able to block both amphetamine-induced locomotor activity and apomorphine-induced stereotypy. Furthermore, A-69024 HBr blocks SF & F 38393-, but not quinpirole-, induced rotation in rats having unilateral 6-hydroxydopamine lesions of the substantia nigra. When administered at behaviorally effective doses, A-69024 HBr neither increases the concentration of serum prolactin nor potentiates dihydroxyphenylalanine (DOPA) accumulation in the caudate-putamen of rats pretreated with the DOPA decarboxylase inhibitor NSD 1015. Because A-69024 is a dopamine receptor antagonist discriminating between the D-1 and D-2 receptors, it may be a useful research tool.

References (33)

  • J. Arnt et al.

    Differential involvement of dopamine D-1 and D-2 receptors in the circling behavior induced by apomorphine, SK&F38393, pergolide and LY171555 in 6-hydroxydopamine-lesioned rats

    Psychopharmacology

    (1985)
  • P.S. Charifson et al.

    Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands

    J. Med. Chem.

    (1988)
  • Y.C. Cheng et al.

    Relationship between the inhibition constant (Ki) and the concentration of the inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction

    Biochem. Pharmacol.

    (1973)
  • D. Clark et al.

    D1 dopamine receptor - the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

    Synapse

    (1987)
  • T.E. Cote et al.

    D-2 dopamine receptor-mediated inhibition of adenylate cyclase activity in the intermediate lobe of the rat pituitary gland requires guanosine 5′-triphosphate

    Endocrinology

    (1982)
  • P. Dostert et al.

    Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases

    J. Neural Transm.

    (1988)
  • Cited by (34)

    View all citing articles on Scopus
    View full text